CABAZITAXEL DR.REDDY'S cabazitaxel 60 mg/1.5 mL concentrated injection vial

Negara: Australia

Bahasa: Inggris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

cabazitaxel, Quantity: 60 mg

Tersedia dari:

Dr Reddys Laboratories Australia Pty Ltd

Bentuk farmasi:

Injection, concentrated

Komposisi:

Excipient Ingredients: polysorbate 80; citric acid

Rute administrasi :

Intravenous Infusion

Unit dalam paket:

1

Jenis Resep:

(S4) Prescription Only Medicine

Indikasi Terapi:

Cabazitaxel Dr.Reddy?s in combination with prednisone or prednisolone is indicated for the treatment of patients with metastatic castration resistant prostate cancer previously treated with a docetaxel containing regimen.

Ringkasan produk:

Visual Identification: Clear yellow to brownish-yellow viscous solution.; Container Type: Multiple containers; Container Material: Glass; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status otorisasi:

Registered

Tanggal Otorisasi:

2018-07-23